Antisense modulation of PI3 kinase p110 beta expression
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 17, 2000
Grant Date -
N/A
app pub date -
Sep 9, 1999
filing date -
Sep 9, 1999
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of PI3 kinase p110 beta. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PI3 kinase p110 beta. Methods of using these compounds for modulation of PI3 kinase p110 beta expression and for treatment of diseases associated with expression of PI3 kinase p110 beta are provided.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully